Schultes Birgit C sold NTLA
January 5, 2026 · Form 4 insider transaction
Schultes Birgit C sold 8,508 shares of Intellia Therapeutics, Inc. at $9.21 per share, a transaction worth $78.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,508
Price
$9.21
Total value
$78.4K
InsiderSchultes Birgit C
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after98,533
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.; Includes 925 and 932 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025, respectively.